Project Grant 2134701

Award Date 11/15/21
Completion Date 10/31/23
Dollars Obligated $500K
Federal Grant Program
47.074
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30332, USA
Similar Awards
This four-year, $708,333 National Science Foundation project grant funds research at Georgia Tech Research Corporation to develop genetic and microfluidic technologies to direct the differentiation of human induced pluripotent stem cell-derived retinal organoids. Specifically, the researchers will apply genome-wide methods leveraging both cell differentiation and biomechanical properties to screen for pathways that regulate retinogenesis. Systems biology approaches will identify master...
This Project Grant from the National Science Foundation's Division of Chemical, Bioengineering, Environmental, and Transport Systems Engineering Directorate will support $541,665 in research at The University of Iowa from October 2022 through September 2026. The grant aims to advance control of human induced pluripotent stem cell differentiation to retinal cells through genomic and microfluidic techniques. Researchers will develop genome-wide methods leveraging cell differentiation properties...
The Georgia Tech Research Corporation was awarded a $1,077,799 project grant from the National Science Foundation Division of Molecular and Cellular Biosciences on September 1, 2021 to complete work by August 31, 2025. The grant falls under the Biological Sciences program (CFDA 47.074), which aims to promote progress in the biological sciences and strengthen the nation's scientific enterprise through increasing knowledge and enhancing understanding of major problems. Specifically, the grant will...
This $500,000 National Science Foundation project grant supports research to advance the biom anufacturing of extracellular vesicles through the integration of human induced pluripotent stem cell technology, genome engineering, and membrane nanofabrication. The primary recipient is Syracuse University, with Rochester Institute of Technology serving as a sub-awardee. Under the Biological Sciences program (CFDA 47.074), the grantees will work to generate a stable human iPSC line with enhanced EV...
This $600,120 federal Project Grant award from the National Science Foundation (NSF) Biological Sciences (CFDA 47.074) program supports the development of a groundbreaking microfluidic-based instrument capable of measuring the mass of individual live cells with picogram-level accuracy and millisecond-scale temporal resolution. The innovative instrument uses small pipettes to gently capture cells and precisely detect mass changes, enabling continuous monitoring of crucial cellular processes...
This $1,000,000 National Science Foundation project grant supports research at the University of Wisconsin-Madison to develop single cell-level programming of human induced pluripotent stem cell differentiation into chamber-specific cardiomyocytes. The goal is to generate cardiomyocytes from each chamber of the heart through precise control of Wnt and retinoic acid signaling at the single cell level via engineered genetic programs and superstructures. If successful, this approach could establish...
This $125,805 Project Grant award from the National Science Foundation (NSF) Engineering program (CFDA 47.041) aims to develop new cell sorting technologies that can identify and separate cells based on changes in the activity of naturally occurring light-emitting molecules like NAD(P)H. The goal is to enable label-free, rapid identification and purification of cell populations, with a focus on stem cells and their functional subsets. The research will create a single cell deposition module to...
This National Science Foundation (NSF) Engineering Program (CFDA 47.041) Project Grant award of $600,000 to Dartmouth College aims to develop methodologies for efficiently manufacturing mature human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) to accelerate drug development and cardiac disease modeling. The project will employ biochip design, machine learning, developmental biology, and tissue engineering approaches to enhance the structural and functional maturity of...
This $429,999 Project Grant was awarded on March 1, 2025 by the National Science Foundation (NSF) Division of Molecular and Cellular Biosciences under the Biological Sciences federal grant program (CFDA 47.074). The grant supports research to develop a method for implanting microelectronic chips into living cells to sense and "rewire" cellular signaling pathways. The goal is to create a new tool for studying how cells make decisions and carry out complex behaviors by modifying the...
The National Science Foundation (NSF) awarded a $300,000 Project Grant under its Biological Sciences program (CFDA 47.074) to the Georgia TECH Research Corporation for the "TOOLS4CELLS: EAGER: A MOLECULAR PURSUIT FOR THE ENGRAM: MICROFLUIDIC TEMPORAL TRANSCRIPTOMICS FOR SINGLE CELL LEARNING" project. This 2-year effort aims to develop innovative microfluidic tools and workflows to investigate the role of non-coding RNA in learning and memory storage in single-celled organisms. Key...

This $500,000 Project Grant from the National Science Foundation Division of Molecular and Cellular Biosciences, under the Biological Sciences federal grant program (CFDA 47.074), will support research to develop an end-to-end continuous manufacturing process for cell therapies using robotics and microfluidic technologies. The Georgia Tech Research Corporation will receive funding to create a more integrated workflow based on microfluidic device-enabled genetic engineering, cell expansion, and label-free cell purification techniques. These technologies will be applied to an induced pluripotent stem cell-derived retinal organoid manufacturing process. Under a subaward, researchers at The University of Iowa will work to demonstrate vector design for CRISPR/Cas9 gene correction, differentiation of iPSCs to retinal phenotypes, and generation of retinal organoids following cell separation using the new microfluidic and robotic methods. The goal is to establish a more continuous and automated production process that enables nimbler process control in compliance with cGMP standards for generating functional retinal cell grafts.

Generated 1/6/24, 11:09 PM